CENTER FOR DRUG EVALUATION AND RESEARCH KEY OFFICIALS April 10, 2018 OFFICE OF THE CENTER DIRECTOR (OCD) DIRECTOR Janet Woodcock, M.D. 301-796-5400 WO 51/Rm. 6133 Executive Assistant to Dr. Woodcock Sharnell Ligon 301-796-5400 WO 51/Rm. 6131 Special Assistant to Dr. Woodcock Devota DeMarco 301-796-3605 WO 51/Rm. 6124 Deputy Director Regulatory Programs Douglas C. Throckmorton, M.D. 301-796-5400 WO 51/Rm. 6132 Executive Assistant to Dr. Throckmorton Wynnet Green 301-796-1103 WO 51/Rm. 6128 Deputy Director Clinical Science Robert J. Temple, M.D. 301-796-2270 WO 22/Rm. 4212 Executive Assistant to Dr. Temple Aprile Blount 301-796-1079 WO 22/Rm. 4221 Special Assistant to Dr. Temple Melina Griffs 301-796-1078 WO 22/Rm. 4206 Deputy Director Science Operations Vacant Executive Assistant to Deputy Director Science Operations LaToya Richardson 240-402-4037 WO 51/Rm. 6126 Associate Director Drug Safety Operations Theresa Toigo, R.Ph., M.B.A. 301-796-8473 WO 51/Rm. 6156 Associate Director for Compounding Julie Dohm 301-796-8732 WO 51/RM. 6140 Project Manager Georgiann Lenzi 301-796-3515 WO 51/Rm. 5159 Controlled Substance Staff (CSS) Director Dominic Chiapperino (Acting) 301-796-1183 WO 51/Rm. 5148 Professional Affairs and Stakeholder Engagement Staff (PASES) Director
35
Embed
CDER Key Officials List - Food and Drug Administration · PDF filecenter for drug evaluation and research . key officials . january 16, 2018 . office of the center director (ocd) director
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
CENTER FOR DRUG EVALUATION AND RESEARCH KEY OFFICIALS
April 10, 2018
OFFICE OF THE CENTER DIRECTOR (OCD)
DIRECTOR Janet Woodcock, M.D. 301-796-5400 WO 51/Rm. 6133
Executive Assistant to Dr. Woodcock Sharnell Ligon 301-796-5400 WO 51/Rm. 6131
Special Assistant to Dr. Woodcock Devota DeMarco 301-796-3605 WO 51/Rm. 6124
Deputy Director Regulatory Programs Douglas C. Throckmorton, M.D. 301-796-5400 WO 51/Rm. 6132 Executive Assistant to Dr. Throckmorton Wynnet Green 301-796-1103 WO 51/Rm. 6128 Deputy Director Clinical Science Robert J. Temple, M.D. 301-796-2270 WO 22/Rm. 4212
Executive Assistant to Dr. Temple Aprile Blount 301-796-1079 WO 22/Rm. 4221 Special Assistant to Dr. Temple Melina Griffs 301-796-1078 WO 22/Rm. 4206 Deputy Director Science Operations Vacant Executive Assistant to Deputy Director Science Operations LaToya Richardson 240-402-4037 WO 51/Rm. 6126 Associate Director Drug Safety Operations
Theresa Toigo, R.Ph., M.B.A. 301-796-8473 WO 51/Rm. 6156 Associate Director for Compounding Julie Dohm 301-796-8732 WO 51/RM. 6140 Project Manager Georgiann Lenzi 301-796-3515 WO 51/Rm. 5159
Controlled Substance Staff (CSS) Director Dominic Chiapperino (Acting) 301-796-1183 WO 51/Rm. 5148 Professional Affairs and Stakeholder Engagement Staff (PASES) Director
John J. Whyte, M.D. M.Ph. 240-402-4121 WO 51/Rm. 2342 Counter-Terrorism and Emergency Coordination Staff (CTECS) Director Rosemary Roberts, M.D. 301-796-1740 Hillandale/Rm. 2128 Drug Shortage Staff (DSS) Director Valerie Jensen 301-796-0737 WO 22/Rm. 6204
OFFICE OF REGULATORY POLICY (ORP) DIRECTOR Grail Sipes, J.D. 301-796-5122 WO 51/Rm. 6244
Deputy Director Carol Bennett, J.D. 301-796-0037 WO 51/Rm. 6276
Executive Assistant Laura DeGrouchy 301-796-3632 WO 51/Rm. 6269
Administrative Management Team
Senior Manager Officer Kelley Hill 301-796-3706 WO 51/Rm. 6252
Division of Regulatory Policy I (DRPI) Director Nancy Hayes, J.D. 301-796-5211 WO 51/Rm. 6244 Division of Regulatory Policy II (DRPII) Director Michael Bernstein, J.D. 301-796-3478 WO 51/Rm. 6240 Division of Regulatory Policy III (DRPIII) Director Nam Kim, J.D. 301-796-3472 WO 51/Rm. 6320 Division of Regulatory Policy IV (DRPIV) Director David Joy, J.D. 301-796-2242 WO 51/Rm. 6254 Division of Information Disclosure Policy (DIDP) Director Nancy Sager 301-796-3491 WO 51/Rm. 6264 Deputy Director Howard Philips, J.D. 301-796-3483 Hillandale/Rm.3172
Proactive Disclosure Branch (PDB) Branch Chief Carol Doyle 301-796-3492 Hillandale/Rm.3152
Freedom of Information Branch (FOIB) Branch Chief Sudarshini (Darshini) Satchi, J.D. 301-796-3496 Hillandale/Rm.3130
OFFICE OF EXECUTIVE PROGRAMS (OEP)
DIRECTOR Mary Beth Clarke 301-796-2859 WO 51/Rm. 6144
Deputy Director Heather Brown 301-796-4304 WO51/Rm. 6156
Executive Assistant Cheryl Giganti 240-402-8294 WO 51/Rm. 6145 Ombudsman Virginia Behr 301-796-3436 WO 51/Rm. 6158 Senior Management Officer Christopher Carlsen 301-796-7629 WO 51/Rm. 6110 Product Jurisdictional Officer Cherryn Chang 301-796-2454 WO 51/Rm. 6155
Lead Administrative Officer
Stephanie Donovan 301-796-2860 WO 51/Rm. 6114
Division of Learning and Organizational Development (DLOD) Director Valerie Ostach-Fagan (Acting) 240-402-4982 WO 51/Rm. 2374 Deputy Director Valerie Ostach-Fagan 240-402-4982 WO 51/Rm. 2374
Scientific and Regulatory Education Branch (SREB) Branch Chief Shefali Doshi 301-796-1780 WO 51/Rm. 2320 Training Design and Delivery Branch (TDDB) Branch Chief Valerie Ostach-Fagan 240-402-4982 WO 51/Rm. 2374 Leadership and Organizational Development Branch (LODB) Branch Chief Valerie Ostach-Fagan 240-402-4982 WO 51/Rm. 2374
Division of Executive Operations (DEO) Director
Johanna McLatchy (Acting) 301-796-3788 WO 51/Rm. 6180 Deputy Director Vacant
Division of Advisory Committee and Consultant Management (DACCM)
Director Jayne Peterson 301-796- 9024 WO 51/Rm. 2422 Deputy Director Cicely Reese 301-796-9025 WO 31/Rm. 2420
OFFICE OF MANAGEMENT (OM)
DIRECTOR Edwin Echegoyen, M.B.A. (Acting) 301-796-3300 WO 51//Rm. 5132 Executive Assistant Edgar Ovando-Sidotti (Acting) 301-796-3300 WO 51//Rm. 5137
Deputy Director Kevin Laser (Acting) 301-796-3300 WO 51//Rm. 5132
Special Project and Initiative Staff (SPIS) Director
Edwin Echegoyen (Acting) 301-796-3300 WO 51/Rm. 5134 Ethics Liaison Staff (ELS) Director Patricia Reilly 301-796-7818 WO 51/Rm. 5158 Policies and Procedures Team Team Lead John Friel 301-796-3173 WO 51/Rm. 5116 Administrative Team Supervisory Administrative Officer Tracy Bellamy-Anderson 240-402-4140 WO 51/Rm. 5128
Division of Budget Execution and Resource Management (DBERM) Director David Caines (Acting) 240-402-0555 WO 51/Rm. 1264
Deputy Director Rixie Scott 301-796-4405 WO 51/Rm. 1260 Budget Execution Branch (BEB) Branch Chief Elizabeth Wyatt (Acting) 301-796-2136 WO 51/Rm. 1276
Financial Accountability Branch (FAB)
Branch Chief Don Kim 301-796-4407 WO 51/Rm. 1256
Acquisitions Support Branch (ASB) Branch Chief
Beth Goldberg 240-402-5101 WO 51/Rm. 1272 Division of Management Services (DMS) Director Mary Milline 301-796-4428 WO 51/Rm. 1348
Associate Director for Human Capital Jacquita Johnson-House 301-796-4148 WO 51/Rm. 1352
Associate Director for Logistics Management Angela Harris 301-796-4450 WO 51/Rm. 1344 Human Capital Management Branch (HCMB)
Branch Chief Cheryl Parker (Acting) 240-402-4323 WO 51/Rm. 1358
Human Capital Programs Branch (HCPB) Branch Chief
Zina Freeman 240-402-0038 WO 51/Rm. 1316
Facilities Operations Branch (FOB) Branch Chief
Thomas Giganti 240-276-9487 WO 51/Rm. 1370
Property and Travel Services Branch (PTSB) Branch Chief Debora Breeden 301-796-4460 WO 51/Rm. 1228
Leave and Performance Management Branch (LPMB) Branch Chief
Regina Shumate (Acting) 301-796-5364 WO 51/Rm. 1330 Division of User Fee Management and Budget Formulation (DUFMBF) Director Donal Parks 301-796-3848 Hillandale/Rm.2107 Deputy Director Lisa Berry 301-796-7225 Hillandale/Rm.2174 Generics Branch (GB)
Branch Chief Gisa Perez 301-796-4178 Hillandale/Rm.2106 Policy and Operations Branch (POB)
OFFICE OF COMMUNICATIONS (OCOMM) DIRECTOR Christine Shreeve 301-796-3818 Hillandale/Rm.1126
Deputy Director Kimberly Rawlings 301-796-3818 Hillandale/Rm.1146 Associate Director for Research and Risk Communications Paula Rausch, Ph.D., R.N. 301-796-3121 Hillandale/Rm.1144 Executive Assistants Joyce Harrell 301-796-3700 Hillandale/Rm.1127 Senior Management Officer Linda Tran 301-796-3636 Hillandale/Rm.1136
Division of Online Communications (DOC) Director Paul Buckman, M.S. 301-796-3135 Hillandale/Rm.1106
Deputy Director Sally Winthrop, M.L.S. 301-796-3135 Hillandale/Rm.1122
Division of Health Communications (DHC) Director Lauren Shaham 301-796-3518 Hillandale/Rm.4110
Deputy Director Vacant
Division of Drug Information (DDI) Director Mary Kremzner, Pharm.D., M.P.H. 301-796-3144 Hillandale/Rm.4150
Deputy Director Catherine Chew, Pharm.D. 301-796-3166 Hillandale/Rm.4130
OFFICE OF COMPLIANCE (OC) DIRECTOR Donald D. Ashley, J.D. 301-796-3100 WO 51/Rm. 5270
Deputy Director Ilisa Bernstein, Pharm.D., J.D. 301-796-4723 WO 51/Rm. 5266 Deputy Director
Mike Levy, J.D. 301-796-3314 WO 51/Rm. 5276 Special Assistants Sarah Barkow (Acting) 301-796-0318 WO 51/Rm. 5272 Eunah Kostal, MBA 301-796-7435 WO 51/Rm. 5260 Executive Assistant Nyala Johnson 240-402-0068 WO 51/Rm. 5269 Senior Advisor for Special Projects Allen Lou 301-796-5652 `WO 51/Rm. 5272
Senior Regulatory Advisor Vacant Regulatory Counsel Davina R. Marano 240-402-0053 WO 51/Rm. 5263
Senior Medical Advisor John Troiani, M.D., Ph.D. 301-796-4258 WO 51/Rm. 5281
Advisor for Communications Sarah Clark-Lynn (Acting) 301-796-9110 WO 51/Rm. 5263
Program Management and Analysis Staff (PMAS) Director Collin Figueroa 301-796-5802 WO 51/Rm. 5250
Office of Manufacturing Quality (OMQ) Director
Francis Godwin (Acting) 301-796-5362 WO 51/Rm. 4352 Deputy Director for Management and Operations Kennerly K. Chapman 301-796-3271 WO 51/Rm. 4346
Deputy Director for Science and Regulatory Policy Richard L. Friedman 301-796-3268 WO 51/Rm. 4348
Senior Advisor for Regulatory Science Vacant
Associate Director for Quality Assurance Vacant Special Assistant Ellen Kempler 301-796-3753 WO 51/Rm. 4337
Manufacturing Quality Guidance and Policy Staff (MGPS) Director Paula R. Katz, J.D. 301-796-6972 WO 51/Rm. 4330 Division of Drug Quality I (DDQI)
Director Carmelo Rosa 301-796-3667 WO 51/Rm. 4354
Global Compliance Branch I (GCBI) Branch Chief Ian Deveau 301-796-5061 WO 51/Rm. 4366
Global Compliance Branch II (GCBII) Branch Chief Maan Abduldayem 301-796-3916 WO 51/Rm. 4360
Division of Drug Quality II (DDQII) Director Milind Ganjawala 301-796-3318 WO 51/Rm. 4322
Global Compliance Branch III (GCBIII) Branch Chief Milind Ganjawala 301-796-3318 WO 51/Rm. 4352
Global Compliance Branch IV (GCBIV) Branch Chief Tamara Felton-Clark 301-796-4162 WO 51/Rm. 4362
Office of Unapproved Drugs and Labeling Compliance (OUDLC)
Director Carolyn Becker, J.D. 301-796-8801 WO 51/Rm. 5188 Deputy Director Kathleen Anderson, Pharm.D. 301-796-3309 WO 51/Rm. 5182
Senior Advisor for Market Surveillance and Data Analysis Meghan Murphy, Ph.D. 301-796-3307 WO 51/Rm. 5178
Senior Advisor for Policy Sara Rothman, M.P.H. 301-796-3536 WO 51/Rm. 5197 Senior Advisor for Regulatory Sciences Huascar Batista, M.P.H. 301-796-3411 WO 51/Rm. 5164 Senior Medical Advisor Arthur Simone, M.D. 301-796-1294 WO 51/Rm. 5186
Division of Prescription Drugs (DPD) Director Gail Bormel, R.Ph., J.D. 301-796-3263 WO 51/Rm. 5184
Prescription Drugs Branch (PDB) Branch Chief James Flahive, J.D. 301-796-9293 WO 51/Rm. 5180
Compounding and Pharmacy Practices Branch (CPPB)
Branch Chief Edisa Gozun 301-796-1068 WO 51/Rm. 5196
Division of Non-Prescription Drugs and Health Fraud (DNPDHF) Director John (Brad) Pace, J.D. 301-796-3538 WO 51/Rm. 5174
Over-the-Counter Drugs Branch (OTCDB)
Branch Chief Tina Smith 301-796-2249 WO 51/Rm. 5178
Health Fraud Branch (HFB) Branch Chief Cynthia Ng (Acting) 301-196-7512 WO 51/Rm. 5109
Office of Drug Security, Integrity and Response (ODSIR) Director Thomas (T.J.) Christl 301-796-2057 WO 51/Rm. 4274 Deputy Director Meredith Francis, J.D. 301-796-3476 WO 51/Rm. 4266 Senior Advisor for Policy Connie Jung, R.Ph., Ph.D. 301-796-4712 WO 51/Rm. 4268
Division of Import Exports and Recalls (DIER) Director Carole Jones 301-796-3194 WO 66/Rm. 3654
Branch Chief Andrei Perlloni 301-796-8258 WO 51/Rm. 4278
Division of Supply Chain Integrity (DSCI) Director Eleni Anagnostiadis, R.Ph. 301-796-7606 WO 51/Rm. 4272
Supply Chain Strategy and Policy Branch (SCSPB) Branch Chief Tia M. Harper-Velazquez,Pharm.D.,J.D.301-796-3301 WO 51/Rm. 4262
Supply Chain Response and Enforcement Branch (SCREB) Branch Chief Sangeeta Vaswani Chatterjee 301-796-9256 WO 51/Rm. 4288
Office of Program and Regulatory Operations (OPRO) Director Maria Rossana (Rosemary) Cook, MBA 301-348-3968 WO 51/Rm. 5278
Deputy Director Yuexia Li, PhD 301-796-2155 WO 51/Rm. 5282 Special Assistant Amina Gilyard, MEd 240-402-5514 WO 51/Rm. 5283
Project Management and Coordination Staff I (PMSCI) Director
Carlene (Cai) Randolph, MS, MBA, PhD 240-402-8761 WO 51/Rm. 5286
Project Management and Coordination Staff II (PMSCII) Director
Melissa Hulett, MBA 301-796-4897 WO 51/Rm. 5254
Drug Registration and Listing Staff (DRLS) Director Paul Loebach 301-796-2173 WO 51/Rm. 2262
Office of Scientific Investigations (OSI) Director David Burrow, Pharm.D., J.D. (Acting) 301-796-5632 WO 51/Rm. 5348 Deputy Director David Burrow, Pharm.D., J.D. 301-796-5632 WO 51/Rm. 5348 Special Assistant Kavita C. Dada, Pharm.D. 301-796-6954 WO 51/Rm. 5358
Associate Director for Regulatory Affairs Kavita C. Dada, Pharm.D. (Acting) 301-796-6954 WO 51/Rm. 5358 Senior Advisor for Policy Mathew T. Thomas, M.D. 301-796-8684 WO 51/Rm. 5342
Policy Staff (PS)
Director Emily Gebbia, J.D. 240-402-0980 WO 51/Rm. 5262
Division of Enforcement and Postmarketing Safety (DEPS)
Director Sherry Bous, Pharm.D. 240-402-8176 WO 51/Rm. 5364
Compliance Enforcement Branch (CEB) Branch Chief Adam Donat 301-796-5316 WO 51/Rm. 5352
Postmarketing Safety Branch (PSB) Branch Chief LaShanda Long, M.S. 301-796-5465 WO 51/Rm. 5356
Division of Clinical Compliance Evaluation (DCCE)
Director Ni Aye Khin, M.D. 301-796-0911 WO 51/Rm. 5334
Good Clinical Practice Compliance Oversight Branch (GCPCOB) Branch Chief Constance Cullity, M.D., M.P.H. 301-796-3397 WO 51/Rm. 5354
Good Clinical Practice Assessment Branch (GCPAB) Branch Chief Kassa Ayalew, M.D., M.P.H. 301-796-0670 WO 51/Rm. 5370
OFFICE OF MEDICAL POLICY (OMP) DIRECTOR Jaqueline Corrigan-Curay, J.D., M.D. 301-796-2500 WO 51/Rm. 6338
Assistant Chris Plummer 301-796-0965 WO 51/Rm. 6337 Deputy Director Mohammed ElZarrad 301-796-8613 WO 51/Rm. 6342
Associate Director for Clinical Methodology Leonard Sacks, M.D. 301-796-8502 WO 51/Rm. 6326 Associate Director for Regulatory Affairs Dianne Paraoan 301-796-3161 WO 51/Rm. 3326
Senior Management Officer Debbie Begosh 301-796-1588 WO 51/Rm. 6334
Office of Prescription Drug Promotion (OPDP) Director Thomas W. Abrams, R.Ph., M.B.A. 301-796-1200 WO 51/Rm. 3314 Deputy Director CAPT Mark Askine 301-796-1200 WO 51/Rm. 3264
Division of Advertising and Promotion Review II (DAPRII) Director
Robert Dean 301-796-2215 WO 51/Rm. 3274
Deputy Director Twyla Thompson 301-796-4294 WO 51/Rm. 3282
Division of Advertising and Promotion Review I (DAPRI) Director CAPT Andrew Haffer 301-796-1200 WO 51/Rm. 3272
Deputy Director CAPT Lisa Hubbard 301-796-1200 WO 51/Rm. 3270
Office of Medial Policy Initiatives (OMPI) Director CAPT Philip Budashewitz 301-796-0577 WO 51/Rm. 6320
Deputy Director Vacant
Associate Director for Regulatory Affairs Vacant
Division of Medical Policy Development (DMPD) Director LCDR Jessica Cleck-Derenick 301-796-0390 WO 51/Rm. 6352
Deputy Director Vacant Division of Medical Policy Programs (DMPP) Director Bryson Pearsall 301-796-9617 WO 51/Rm. 6326
Deputy Director CDR Jonas Santiago 301-796-5346 WO 51/Rm. 6348 Division of Clinical Trial Quality (DCTQ) Director Alyson Karesh, M.D. 301-796-3824 WO 51/Rm. 6356 Deputy Director Kaveeta Vasisht, M.D. (Acting) 301-796-2920 WO 51/Rm. 3332
OFFICE OF TRANSLATIONAL SCIENCES (OTS)
DIRECTOR ShaAvhree Buckman-Garner, M.D., Ph.D., F.A.A.P. 301-796-2600 WO 21/Rm. 4554
Deputy Director
Mitra Ahadpour, M.D., D.A.B.A.M. 301-796-8469 WO 21/Rm. 4546 Deputy Director for Science
Juan Ruiz, Ph.D., M.B.A. 301-796-0950 WO 21/Rm. 2630 Program Support Specialist Samantha Stiles 301-796-4791 WO 21/Rm. 4545 Director, Program Management & Analysis Staff (PMAS) Raya S. McCree 301-796-1708 WO 21/Rm. 4512
Associate Director for Regulatory Affairs Vacant
OFFICE OF BIOSTATISTICS (OB)
Director Aloka Chakravarty, Ph.D. (Acting) 301-796-1655 WO 21/Rm. 3550
Deputy Director Dionne Price, Ph.D. (Acting) 301-796-1274 WO 21/Rm. 3508
Associate Director Sue Jane Wang, Ph.D. 301-796-0831 WO 21/Rm. 3506
Associate Director for Statistical Science & Policy Thomas Permutt, Ph.D. 301-796-1271 WO 21/Rm. 3614 Associate Director for Biosimilar Review Shein-Chung Chow, Ph.D. 301-796-8712 WO 21/Rm. 3548 Supervisory Administrative Officer Vonda Jewell 301-796-8371 WO 21/Rm. 4506
Administrative Support Assistant Tenika Casey 301-348-1862 WO 21/Rm. 3547
Division of Biometrics I (DBI) Director Hsien-Ming J. Hung, Ph.D. 301-796-1092 WO 21/Rm. 4616
Deputy Director Sue Jane Wang, Ph.D. (Acting) 301-796-0831 WO 21/Rm. 3506
Division of Biometrics II (DBII)
Director Mark Rothmann, Ph.D. (Acting) 301-796-1743 WO 21/Rm. 3616
Deputy Director Gregory Levin (Acting) 301-796-4428 WO 21/Rm. 3612
Division of Biometrics III (DBIII)
Director Laura Lee Johnson, Ph.D. (Acting) 240-402-6142 WO 21/Rm. 3668
Deputy Director Jingyu (Julia) Luan, Ph.D. 301-796-2148 WO 21/Rm. 3626
Division of Biometrics IV (DBIV)
Director Daphne Ty Lin, Ph.D. 301-796-0751 WO 21/Rm. 3604
Deputy Director Daphne Ty Lin, Ph.D. 301-796-0751 WO 21Rm. 3604
Division of Biometrics V (DBV) Director Rajeshwari Sridhara, Ph.D. 301-796-1759 WO 21/Rm. 3512
Deputy Director Thomas Gwise, Ph.D. 301-796-6034 WO 21/Rm. 3546
Division of Biometrics VI (DBVI)
Director Yi Tsong, Ph.D. 301-796-1013 WO 21/Rm. 4630 Deputy Director
Atiar Mohammad Rahman, Ph.D. 301-796-0979 WO 21/Rm. 4657
Division of Biometrics VII (DBVII) Director Mark Levenson, Ph.D. 301-796-2097 WO 21/Rm. 4626 Deputy Director Mat Soukup, Ph.D. 301-796-1005 WO 21/Rm. 4658 Division of Biometrics VIII (DBVIII) Director Stella Grosser, Ph.D. 240-402-3868 WO 21/Rm. 4628 Deputy Director Fairouz Makhlouf, Ph.D. 240-402-3869 WO 21/Rm. 4608 OFFICE OF CLINICAL PHARMACOLOGY (OCP)
Director Issam Zineh, Pharm.D.,M.P.H.,F.C.P.,F.C.C.P. 301-796-4756 WO 51/Rm. 3178
Program Support Specialist Karen Graves 301-796-5008 WO 51/Rm. 3177
Deputy Director Shiew-Mei Huang, Ph.D. 301-796-1541 WO 51/Rm. 3188
Associate Director of Genomics
Michael Pacanowski, Pharm.D., M.P.H. 301-796-3919 WO 51/Rm. 2132
Supervisory Administrative Officer Zachary Mitchell 240-402-3194 WO 21/Rm. 4544
Division of Clinical Pharmacology I (DCPI) Director
Mehul Mehta, Ph.D. 301-796-1573 WO 51/Rm. 2178 Deputy Director Ramana S. Uppoor, Ph.D. 301-796-1619 WO 51/Rm. 2182
Division of Clinical Pharmacology II (DCPII) Director Chandrahas Sahajwalla, Ph.D. 301-796-1599 WO 51/Rm. 3142
Deputy Director Suresh Doddapaneni, Ph.D. 301-796-1526 WO 51/Rm. 3136
Division of Clinical Pharmacology III (DCPIII) Director Shiew-Mei Huang, Ph.D. (Acting) 301-796-1541 WO 51/Rm. 3188
Deputy Director Vacant
Division of Clinical Pharmacology IV (DCPIV) Director John A. Lazor, Pharm.D. 301-796-1559 WO 51/Rm. 2134
Deputy Director Kellie Reynolds, Ph.D. 301-796-1594 WO 51/Rm. 2108
Division of Clinical Pharmacology V (DCPV) Director Nam Atiqur Rahman, Ph.D. 301-796-1591 WO 51/Rm. 2188
Deputy Director Brian Booth, Ph.D. 301-796-1508 WO 51/Rm. 2186
Division of Pharmacometrics (DPM) Director Yaning Wang, Ph.D. 301-796-1624 WO 51/Rm. 2106
Deputy Director Vacant
Division of Applied Regulatory Science (DARS) Director David Strauss, M.D., Ph.D. 301-796-6323 WO 64/Rm. 2072
Deputy Director Vikram Patel, Ph.D. 301-796-0121 WO 64/Rm. 2026
Office of Computational Science (OCS) Director Lilliam Rosario, Ph.D. 301-796-8501 WO 21/Rm. 1510 Deputy Director Vacant
Office of Study Integrity and Surveillance (OSIS) Director Sean Kassim, Ph.D. 301-796-3865 WO 22/Rm. 1442
Deputy Director Sally Choe, Ph.D. 301-796-7960 WO 22/Rm. 1440
Division of New Drug Bioequivalence Evaluation (DNDBE) Director Charles Bonapace, Ph.D. (Acting) 301-796-1507 WO 51/Rm. 5228
Deputy Director Arindam Dasgupta 301-796-3326 WO 51/Rm. 5226
Division of Generic Drug Bioequivalence Evaluation (DGDBE) Director Seongeun (Julia) Cho, Ph.D. 301-796-5032 WO 22/Rm. 1438
Deputy Director John Kadavil (Acting) 240-402-6643 WO 51/Rm. 5372
OFFICE OF SURVEILLANCE AND EPIDEMIOLOGY (OSE)
DIRECTOR Gerald Dal Pan, M.D., M.H.S. 301-796-2380 WO 22/Rm. 4304
Executive Assistant Barbara M. McCary 301-796-2000 WO 22/Rm. 4303
Deputy Director Robert “Bob” Ball, M.D., M.P.H. 240-402-0397 WO 22/Rm. 4300 Associate Director for Public Health Initiatives Judy Staffa, Ph.D. 301-796-2380 WO 22/Rm. 2404 Regulatory Science Staff (RSS) Staff Director Amarilys Vega, M.D. 301-796-2380 WO22/Rm. 4312
Regulatory Affairs Staff (RAS) Staff Director Maureen Melvin, M.S. 301-796-2380 WO22/Rm. 4480
Program Management & Analysis Staff (PMAS) Director Amy Garvin 301-796-3413 WO22/Rm. 4326
Project Management Staff (PMS) Director
Jill Bourdage, R.Ph. 301-796-2380 WO 22/Rm. 4478
Office of Medication Error Prevention and Risk Management (OMEPRM) Director Claudia Manzo, Pharm.D. 301-796-0182 WO 22/Rm. 2418
Deputy Director Lubna Merchant, Pharm.D. (Acting) 301-796-5162 WO 22/Rm. 4408
Division of Medication Errors Prevention and Analysis (DMEPA)
Director Todd Bridges 301-796-2360 WO 22/Rm. 4416
Deputy Director CDR Irene Chan, Pharm.D. 301-796-2360 WO 22/Rm. 4420
Division of Risk Management (DRISK) Director Cynthia LaCivita, Pharm.D. 301-796-0307 WO 22/Rm. 2424
Deputy Director Jamie Wilkins-Parker 301-796-6113 WO 22/Rm. 2428
Office of Pharmacovigilance & Epidemiology (OPE)
Director Judith Zander, M.D. 301-796-2350 WO 22/Rm. 3474
Deputy Director Michael Blum, M.D. 301-796-2350 WO 22/Rm. 3478
Division of Epidemiology I (DEPI) Director Simone Pinheiro 301-796-2370 WO 22/Rm. 2472
Deputy Director CDR Sukminder Sandhu 301-796-0162 WO 22/Rm. 2470 Division of Epidemiology II (DEPII) Director CDR David Money, R.Ph., M.P.H. 301-796-0507 WO 22/Rm. 2474
Deputy Director Lockwood Taylor, Ph.D., M.P.H. 240-420-5229 WO 22/Rm. 2406 Deputy Director for Drug Use LCDR Grace Chai, Pharm.D. 301-796-5116 WO 22/Rm. 2464
Division of Pharmacovigilance I (DPVI)
Director Cynthia Kortepeter, Pharm.D. 301-796-1110 WO 22/Rm. 3418
Deputy Director LCDR Monica Muñoz, Ph.D., M.S. 301-796-3698 WO 22/Rm. 3400
Division of Pharmacovigilance II (DPVII) Director CDR S. Chris Jones, Pharm.D. 301-796-1463 WO 22/Rm. 3464 Deputy Director CDR Ida-Lina Diak, Pharm.D. 301-796-1986 WO 22/Rm. 3412
OFFICE OF STRATEGIC PROGRAMS (OSP)
DIRECTOR Theresa Mullin, Ph.D. 301-796-3800 WO 51/Rm. 1178
Deputy Director Mary Ann Slack 301-796-0603 WO 51/Rm. 1188
Christine Daley 301-796-5249 WO 51/Rm. 1184 Lead Management Officer Kim Bibbs 301-796-1998 WO 22/Rm. 1104
Office of Program & Strategic Analysis (OPSA)
Director Andrew Kish 301-796-5215 WO51/Rm. 1142 Deputy Director Adam Kroetsch 301-796-3842 WO51/Rm. 1168
Program Evaluation & Implementation Staff (PEIS) Director Kim Taylor (Acting) 240-402-5193 WO 51/Rm. 1152
Economics Staff (ES) Director Andreas Schick 301-796-8741 WO 51/Rm. 1186
Performance Analysis and Data Services Staff (PADSS) Director Reza Kasemi-Tabriz 301-796-3686 WO 51/Rm. 1182
Lean Management Staff (LMS) Director Michael Rappel (Acting) 301-796-37260 WO 51/Rm. 1128
Office of Business Informatics (OBI) Director Hilmar Hamann, Ph.D. 301-796-0375 WO 22/Rm. 1124
Deputy Director Gregory Chin 240-402-0388 WO 22/Rm. 1102
Division of Regulatory Review and Drug Safety Services and Solutions (DRRDSSS) Director Jonathan Rappaport 301-796-2893 WO 22/Rm. 1110
Division of Business Management Services and Solutions (DBMSS) Director Atash Mehta 240-402-4190 WO 22/Rm. 1114
Division of Data Management Services and Solutions (DDMSS) Director Vacant Division of Drug Quality and Compliance Services and Solutions (DDQCSS)
Director Vacant
Innovation Management and Architecture Services & Solutions (IMASS) Technical Architect Chao (Ethan) Chen 301-796-7626 WO 22/Rm. 6130
OFFICE OF NEW DRUGS (OND) DIRECTOR Janet Woodcock, M.D. (Acting) 301-796-0700 WO 22/Rm. 6304 Executive Assistant Victor Vail 301-796-3169 WO 22/Rm. 6305 Deputy Director Peter Stein, M.D. 301-796-0189 WO 22/Rm. 6306
Deputy Director Patrick Frey 301-796-3844 WO 22/RM. 6310
Pharmacology / Toxicology Staff (PTS) Associate Director Karen L. Davis Bruno, Ph.D. 301-796-1199 WO 22/Rm. 6428 Regulatory Affairs Team (RAT) Associate Director Patrick Frey (Acting) 301-796-3844 WO 22/Rm. 6310 Learning and Career Development Team (LCDT)
Associate Director Susanne Walker 301-796-5229 WO 22/Rm. 6486
Guidance and Policy Team (GPT)
Associate Director Sally Loewke, M.D. 301-796-0700 WO 22/Rm. 6424 Safety Policy and Research Team (SPRT)
Associate Director Mwango Kashoki, M.D. 301-796-1238 WO 22/Rm. 6310
Labeling Development Team Associate Director
Eric Brodsky, M.D. 301-796-0855 WO 22/Rm. 6485 Clinical Outcomes Assessment Team Associate Director
Elektra Papadopoulos, M.D. 301-796-0967 WO 22/Rm. 6429
Rare Diseases Program (RDP) Associate Director
Jonathan Goldsmith, M.D. 240-402-9959 WO 22/Rm. 6480
Therapeutic Biologics and Biosimilars Team (TBBT) Associate Director
Leah Christl, Ph.D. 301-796-0868 WO 22/Rm. 6426 Associate Director Joseph Franklin, Ph.D.,J.D. 301-796-8583 WO 22/Rm. 6300
Program Management & Analysis Staff (PMAS) Senior Management Officer
Peter Kelchner (Acting) 301-796-7138 WO 22/Rm. 6371 Biomedical Informatics and Regulatory Review Science (MIRRS) Vaishali Popat, M.D., M.P.H. 301-796-3915 WO 22/Rm. 5324 Biomarker Development and Regulatory Science Team (BDRST) Christopher Leptak, M.D., Ph.D. 301-796-0017 WO 22/Rm. 6462
OFFICE OF DRUG EVALUATION I (ODEI) Director Ellis Unger, M.D. 301-796-1157 WO 22/Rm. 4208 Deputy Director Robert Temple, M.D. (Acting) 301-796-2270 WO 22/Rm. 4208 Associate Director for Regulatory Affairs Colleen LoCicero 301-796-2270 WO 22/Rm. 4216 Lead Administrative Officer Donna Wade 301-796-4910 WO 22/Rm. 4204
Division of Cardiovascular and Renal Products (DCRP)
Director Norman Stockbridge, M.D. Ph.D. 301-796-2240 WO 22/Rm. 4168 Deputy Director Stephen Grant, M.D. 301-796-2277 WO 22/Rm. 4170
Deputy Director for Safety Mary Ross Southworth, M.D. 301-796-0539 WO 22/Rm. 4238
Supervisory Project Manager Edward Fromm 301-796-2240 WO 22/Rm. 4162
Division of Neurology Products (DNP) Director William Dunn, M.D. 301-796-2250 WO 22/Rm. 4338 Deputy Director Eric Bastings, M.D. 301-796-2250 WO 22/Rm. 4338 Deputy Director for Safety Alice Hughes 301-796-1091 WO 22/Rm. 4232
Supervisory Project Manager Jacqueline Ware, R.Ph. 301-769-2250 WO 22/Rm. 4346 Lois Freed, M.D. 301-796-1070 WO 22/Rm. 4370
Division of Psychiatry Products (DPP)
Director Mitchell Mathis, M.D. 301-796-1705 WO 22/Rm. 4112 Deputy Director
Tiffany Farchione, M.D. 301-796-7638 WO 22/Rm. 4110 Deputy Director for Safety Marc Stone, M.D. 301-796-1149 WO 22/Rm. 4122
Supervisory Project Managers Steven Hardeman, R.Ph. 301-796-1081 WO 22/Rm. 4390 Paul David, R.Ph. 301-796-2260 WO 22/Rm. 4100
OFFICE OF DRUG EVALUATION II (ODEII) Director Curtis Rosebraugh, M.D., M.P.H. 301-796-2310 WO 22/Rm. 3214 Deputy Director
Mary Thanh Hai, M.D. 301-796-2310 WO 22/Rm. 3210
Regulatory Information Specialist Velma Cunningham 301-796-1197 WO 22/Rm. 3221 Project Specialist
Misbah Baig 301-796-1169 WO 22/Rm. 3217 Associate Director for Regulatory Affairs Sara Stradley 301-796-1298 WO 22/Rm. 3206 Associate Director for Regulatory Science Silvana Borges, M.D. 301-796-0963 WO 22/Rm. 3200 Lead Management Officer Thomas Cunningham 301-796-1196 WO 22/Rm. 3218
Division of Metabolism and Endocrinology Products (DMEP) Director Mary Thanh-Hai, M.D. 301-796-2310 WO 22/Rm. 3210
Deputy Director James Smith, M.D. 301-796-1317 WO 22/Rm. 3372 Deputy Director for Safety Jennifer Pippins, M.D. 301-796-5067 WO 22/Rm. 3319
Chief, Project Management Staff Julie Van der Waag, M.P.H. 301-796-1280 WO 22/Rm. 3350 Pamela Lucarelli 301-796-3961 WO 22/Rm. 3364
Administrative Officer Nicole Cooper 301-796-1193 WO 22/Rm. 3218
Division of Pulmonary, Allergy and Rheumatology Products (DPARP) Director
Badrul Chowdhury, M.D., Ph.D. 301-796-2300 WO 22/Rm. 3326
Deputy Director Lydia Gilbert-McClain, M.D. 301-796-1215 WO 22/Rm. 3330
Deputy Director of Safety Sally Seymour, M.D. 301-796-1290 WO 22/Rm. 3208 Chief, Project Management Staff Sandra L. Barnes 301-796-1174 WO 22/Rm. 3312 Ladan Jafari 301-796-1231 WO 22/Rm. 3320
Administrative Officer Stanley Allen 301-796-1169 WO 22/Rm. 3223
Division of Anesthetics, Analgesia and Addiction Products (DAAAP) Director Sharon Hertz, M.D. 301-796-2280 WO 22/Rm. 3156
Deputy Director Rigoberto Roca, M.D. 301-796-2280 WO 22/Rm. 3152 Deputy Director Ellen Fields, M.D. 301-796-2280 WO 22/Rm. 3160
Deputy Director for Safety Judith Racoosin, M.D., M.P.H. 301-796-2280 WO 22/Rm. 3158 Chief, Project Management Staff Parinda Jani 301-796-1232 WO 22/Rm. 3166 Matthew Sullivan 301-796-1245 WO 22/Rm. 3168
Administrative Officer Keisha Charles 240-402-9034 WO 22/Rm. 3223
OFFICE OF DRUG EVALUATION III (ODEIII) Director Julie Beitz, M.D. 301-796-0848 WO 22/Rm. 5214
Deputy Director Victor Crentsil 301-796-1047 WO 22/Rm. 5344
Associate Director for Regulatory Affairs Richard (Wes) Ishihara 301-796-0069 WO 22/Rm. 5208
Regulatory Scientist Julieann DeBeau 301-796-0883 WO 22/Rm. 5206
Management Officer Antoinette Mason 301-796-0954 WO 22/Rm. 5218
Lead Administrative Officer Vacant
Division of Gastroenterology and Inborn Errors Products (DGIEP) Director Donna Griebel, M.D. 301-796-2120 WO 22/Rm. 5110
Deputy Director Dragos Roman, M.D. 301-796-1285 WO 22/Rm. 5152
Deputy Director for Safety Joyce Korvick, M.D. 301-796-2120 WO 22/Rm. 5102 Supervisory Project Manager
Brian Strongin 301-796-2120 WO 22/Rm. 5116 Division of Bone Reproductive & Urologic Products (DBRUP) Director
Hylton Joffe, M.D. 301-796-1954 WO 22/Rm. 5384
Administrative Officer Deborah Ivey 240-402-5986 WO 22/Rm. 5220 Deputy Director
Audrey Gassman, M.D. 301-796-0897 WO 22/Rm. 5386
Deputy Director for Safety Christine Nguyen, M.D. 301-796-0960 WO 22/Rm. 5330
Safety Regulatory Health Project Manager Meredith Hillig 301-796-1218 WO 22/Rm. 5333
Supervisory Project Managers Margaret Kober 301-796-0934 WO 22/Rm. 5376
Jennifer Mercier 301-796-0957 WO 22/Rm. 5390 Administrative Officer Fustina Lambert (Acting) 240-402-5234 WO 22/Rm. 5520
Division of Dermatology and Dental Products (DDDP)
Director Kendall Marcus, M.D. 301-796-0755 WO 22/Rm. 5202 Deputy Director Jill Lindstrom, M.D. 301-796-0944 WO 22/Rm. 5204 Deputy Director for Safety Tatiana Oussova 301-796-1267 WO 22/Rm. 5164 Supervisory Project Manager Barbara Jean Gould 301-796-4224 WO 22/Rm. 5166
OFFICE OF DRUG EVALUATION IV (ODEIV) Director Charles J. Ganley, M.D. 301-796-0895 WO 22/Rm. 5306
Deputy Director Lesley-Anne Furlong, M.D. 301-796-0892 WO 22/Rm. 5300 Associate Director Susan Johnson, Pharm.D., Ph.D. 301-796-0925 WO 22/Rm. 5309
Project Specialist Fa-ry Grant 240-402-2115 WO 22/Rm. 5301
Associate Director for Regulatory Affairs Jagjit Grewal 301-796-0846 WO 22/Rm. 5305
Associate Director for Regulator Science Jian Wang, Ph.D. 301-796-3846 WO22/Rm. 5309 Associate Director for Informatics
Gary Gensinger 301-796-0589 WO22/Rm. 5307 Lead Administrative Officer Merla Rae Matheny 301-796-0955 WO 22/Rm. 5304
Division of Nonprescription Drug Products (DNDP) Director
Theresa Michele, M.D. 301-796-1593 WO 22/Rm. 5484 Deputy Director Karen M. Mahoney, MD. 301-796-1250 WO 22/Rm. 5486
Deputy Director for Safety Valerie Pratt, M.D. 301-796-1050 WO 22/Rm. 5464 Administrative Support Assistant Dalmas Robinson 301-796-0974 WO 22/Rm. 5479
Administrative Officer Pamela M. Hampton 301-796-0904 WO 22/Rm. 5304 Division of Medical Imaging Products (DMIP)
Director Libero Marzella, M.D. 301-796-1414 WO 22/Rm. 5406
Deputy Director Alexander Gorovets, M.D. 301-796-0901 WO 22/Rm. 5460
Administrative Support Assistant Christina Duarte 240-402-5338 WO 22/Rm. 5429
Deputy Director of Safety Ira Krefting, M.D. 301-796-1135 WO 22/Rm. 5402
Supervisory CSO Kyong Kang 301-796-1970 WO 22/Rm. 5410
Administrative Officer Nikisha Joyner 240-402-9741 WO 22/Rm. 5304 Division of Pediatrics and Maternal Health (DPMH) Director Lynne Yao, M.D. 301-796-2141 WO 22/Rm. 6406 Deputy Director John Alexander, M.D. (Acting) 301-796-0665 WO 22/Rm. 6102 Administrative Officer Maryam Baig 301-796-5263 WO 22/Rm. 5303
OFFICE OF ANTIMICROBIAL PRODUCTS (OAP)
Director Edward M. Cox, M.D., M.P.H. 301-796-1300 WO 22/Rm. 6212
Deputy Director John J. Farley, M.D., M.P.H. 301-796-1300 WO 22/Rm. 6208
Associate Director for Regulatory Affairs Katherine Schumann 301-796-1182 WO 22/Rm. 6242 Associate Director for Medical Countermeasures Barbara Styrt, M.D., M.P.H., 301-796-1300 WO 22/Rm. 6338
Lead Administrative Officer Dana Schuhly 301-796-0806 WO 22/Rm. 6216
Division of Anti-Infective Products (DAIP) Director Sumathi Nambiar, M.D., M.P.H. 301-796-0772 WO 22/Rm. 6236
Deputy Director
Dmitri Iarikov, M.D. (Acting) 301-796-2292 WO 22/Rm. 6376
Supervisory Project Managers Camen DeBellas 301-796-1203 WO 22/Rm. 6120
Maureen Dillon-Parker 301-796-0706 WO 22/Rm. 6182
Division of Anti-Viral Products (DAVP) Director Debra B. Birnkrant, M.D. 301-796-0682 WO 22/Rm. 6332
Karen Winestock 301-796-0834 WO 22/Rm. 6324 Elizabeth Thompson 301-796-0824 WO 22/Rm. 6362
Division Transplant and Ophthalmology Products (DTOP) Director Renata Albrecht, M.D. 301-796-1600 WO 22/Rm. 6164
Deputy Director Wiley A. Chambers, M.D. 301-796-0690 WO 22/Rm. 6108
Supervisory Project Manager Diana Willard 301-796-0833 WO 22/Rm. 6132
Judit Milstein 301-796-0763 WO 22/Rm. 6180
OFFICE OF HEMATOLOGY AND ONCOLOGY PRODUCTS (OHOP) Director
Richard Pazdur, M.D. 301-796-2340 WO 22/Rm. 2212 Deputy Director Gideon Blumenthal (Acting) 301-796-5369 WO 22/Rm. 2247
Regulatory Information Specialist Bertha Mejia 301-796-2131 WO 22/Rm. 2221 Lead Administrative Officer Sabrina Hunter 301-796-2821 WO 22/Rm. 2241 Management and Program Analyst Stanley Allen 301-796-1169 WO 22/Rm. 2215
Associate Director for Regulatory Affairs Tamy Kim, Pharm.D. 301-796-1125 WO 22/Rm. 2206
Associate Director for Oncology Science Greg Reaman, M.D. 301-796-0785 WO 22/Rm. 2202 Regulatory Scientist
Julie Schneider, Ph.D. 240-402-4658 WO 22/Rm. 2110
Division of Oncology Products I (DOPI) Director Julia Beaver (Acting) 240-402-0489 WO 22/Rm. 2100
Deputy Director Amna Ibrahim, M.D. 301-796-1374 WO 22/Rm. 2106
Christy Cottrell 301-796-4256 WO 22/Rm. 2122 Alice Kacuba 301-796-1381 WO 22/Rm. 2104
Division of Hematology Products (DHP) Director Ann T. Farrell, M.D. 301-796-7550 WO 22/Rm. 2114
Deputy Director Edvardas Kaminskas, M.D. 301-796-1383 WO 22/Rm. 2372
Administrative Officer Alexander Levillain 240-402-5646 WO 22/Rm. 2213
Supervisory CSO Theresa Carioti 301-796-2848 WO 22/Rm. 2317 Amy Baird 301-796-4969 WO 22/Rm. 2329
Division of Oncology Products II (DOPII)
Director Patricia Keegan, M.D. 301-796-1387 WO 22/Rm. 2328
Deputy Director Joseph Gootenberg, M.D. 301-796-1362 WO 22/Rm. 2324
Administrative Officer John Brown 301-796-2956 WO 22/Rm. 2215 Supervisory CSO
Melanie Pierce 301-796-1273 WO 22/Rm. 2340 Monica Hughes 301-796-9225 WO 22/Rm. 2306
Division of Hematology Oncology Toxicology Products (DHOT) Director John Leighton, Ph.D. 301-796-1398 WO 22/Rm. 2204
Deputy Director Haleh Saber 301-796-1410 WO 22/Rm. 2117 Management and Program Analyst Stanley Allen 301-796-1169 WO 22/Rm. 2215
OFFICE OF GENERIC DRUGS (OGD) DIRECTOR Kathleen (Cook) Uhl, M.D. 240-402-7920 WO 75/Rm. 1692
Deputy Director John Peters, M.D. 240-402-3876 WO 75/Rm. 1690
Administrative Support Assistant
Michelle Devlin 240-402-2521 WO 75/Rm. 1695
Clinical Safety Surveillance Staff (CSSS) Director Howard Chazin, M.D. 240-402-8271 WO 75/Rm. 1682 Program Management and Analysis Staff (PMAS) Director Carla Jones, M.S. 301-796-7072 WO 75/Rm. 1653 Communications Staff (CS) Director Jordana O’Grady, M.A. 301-796-5345 WO 75/Rm. 1694
Regulatory Affairs Team (RAT)
Supervisory Associate Director
Mary J. Dempsey 240-402-7926 WO 75/Rm. 1708
OFFICE OF RESEARCH AND STANDARDS (ORS) Director
Robert A. Lionberger, Ph.D. 240-402-7957 WO 75/Rm. 4722
Deputy Director Lei Zhang, Ph.D. 301-796-1635 WO 75/Rm. 4724
Division of Therapeutic Performance (DTP)
Director Markham Luke, M.D. 301-796-5556 WO 75/Rm. 4712
Deputy Director Xiaohui (Jeff) Jiang, Ph.D. 240-402-7964 WO 75/Rm. 4716
Division of Quantitative Methods and Modeling (DQMM)
Director Liang Zhao, Ph.D. 240-402-4468 WO 75/Rm. 4702
Deputy Director Myong-Jin Kim, Ph.D. 301-796-1553 WO 75/Rm. 4682
OFFICE OF BIOEQUIVALENCE (OB)
Director Dale Conner, Pharm.D. 240-402-3914 WO 75/Rm. 2718
Deputy Director Trueman Sharp, M.D. 301-796-8191 WO 75/Rm. 2720
Division of Bioequivalence I (DBI)
Director Bing Li, Ph.D. 240-402-3916 WO75/Rm. 2674
Deputy Director
Utpal Munshi, Ph.D. 240-402-3918 WO 75/Rm. 2682 Division of Bioequivalence II (DBII)
Director Ethan Stier, Ph.D. 240-402-3962 WO 75/Rm. 2714
Deputy Director
Xiaojian Jiang, Ph.D. 240-402-3964 WO 75/Rm. 2728
Division of Bioequivalence III (DBIII) Director
Nilufer Tampal, Ph.D. 240-402-3915 WO 75/ Rm. 2688 Deputy Director
April Braddy, Ph.D. 240-402-3917 WO 75/Rm. 2702
Division of Clinical Review
Director Sarah Yim, M.D. 301-796-1960 WO 75/Rm. 2522
Deputy Director Daiva Shetty, M.D. 240-402-3866 WO 75/Rm. 2518
OFFICE OF GENERIC DRUG POLICY (OGDP) Director Maryll Toufanian (Acting) 240-402-7944 WO 75/Rm. 1720
Deputy Director Kristin Davis, J.D. (Acting) 301-796-0418 WO 75/Rm. 1716
Division of Legal & Regulatory Support (DLRS)
Director Christopher Pruitt, J.D. 240-402-4502 WO 75/Rm. 1688
Deputy Director CAPT Martin Shimer, R.Ph. 240-402-8783 WO 75/Rm. 1678 Division of Policy Development (DPD)
Director Martha Nguyen, J.D. 301-796-3471 WO 75/Rm. 1676
Deputy Director Susan Levine, J.D. 240-402-7936 WO 75/Rm. 1674
OFFICE OF REGULATORY OPERATIONS (ORO)
Director Edward (Ted) Sherwood 301-796-1605 WO 75/Rm. 3720
Deputy Director CDR Vincent Sansone, Pharm.D. 240-402-9075 WO 75/Rm. 3722
Division of Labeling Review (DLR)
Director CAPT Chi Ann (Ruby) Wu, Pharm.D. 240-402-8831 WO 75/Rm. 3654
Deputy Director
CAPT Lillie Golson, Pharm.D. 240-402-8638 WO 75/Rm. 3662
Division of Filing Review (DFR) Director Johnny Young, M.A. 240-402-8839 WO 75/Rm. 3640
Deputy Director
Julia Lee, Ph.D. 240-402-8685 WO 75/Rm. 3646
Divison of Project Management (DPM)
Director Denise Toyer McKan, Pharm.D. 240-402-9016 WO 75/Rm. 3702
Deputy Director CAPT Aaron Sigler, Pharm.D. 240-402-8786 WO 75/Rm. 3682
Division of Quality Management Systems (DQMS)
Director Paula McKeever (Acting) 240-402-7937 WO 75/Rm. 3716 Deputy Director CAPT Steven Mazzella, M.B.A. (Acting) 240-402-8754 WO 75/Rm. 3694
OFFICE OF PHARMACEUTICAL QUALITY (OPQ)
DIRECTOR Michael Kopcha, Ph.D.,R.Ph. 301-796-5400 WO 51/Rm. 6133
Deputy Director
Lawrence Yu, Ph.D. 240-402-3116 WO 51/Rm. 4184 Associate Director for Scientific Staff Katherine Tyner (Acting) 301-796-0085 WO 51/RM. 4146
Program Management and Analysis Staff (PMAS) Director Candee Chadwick 301-796-1511 WO 51/Rm. 4188
OFFICE OF BIOTECHNOLOGY PRODUCTS (OBP) Director
Steven Kozlowski, M.D. 301-796-2390 WO 71/Rm. 2230
Deputy Director Jeffrey Baker, Ph.D. 301-796-5356 WO 71/Rm. 2236
Division of Biotechnology Review and Research I (DBRRI)
Director Kathleen Clouse-Strebel, Ph.D. 240-402-9446 WO 71/Rm. 2240
Division of Biotechnology Review and Research II (DBRRII) Director
David Frucht, M.D. 240-402-9533 WO 52-72/Rm. 2302
Division of Biotechnology Review and Research III (DBRRIII) Director
Amy Rosenberg, M.D. 240-402-9789 WO 71/Rm. 2238
Division of Biotechnology Review and Research IV (DBRRIV) Director
Gibbes Johnson, Ph.D. 240-402-9611 WO 52-72/Rm. 2218
OFFICE OF NEW DRUG PRODUCTS (ONDP) Director
Sarah Pope Miksinski, Ph.D. 301-796-1436 WO 75/Rm. 6414 Deputy Director M. Scott Furness, Ph.D. 301-796-0180 WO 75/Rm. 6510
Division of Life Cycle API (DLCAPI) Director David Skanchy, Ph.D. 240-402-8789 WO 75/Rm. 6722
Division of New Drug API (DNDAPI) Director Ali Al Hakim, Ph.D. 301-796-0202 WO 21/Rm. 2524 Division of New Drug Products I (DNDPI) Director Thomas Oliver, Ph.D. 301-796-1728 WO 21/Rm.1602
Division of New Drug Products II (DNDPII) Director Eric Duffy, Ph.D. 301-796-1666 WO 21/Rm. 2614
Division of Biopharmaceutics (DB) Director Paul Seo, Ph.D. 301-796-4874 WO 21/Rm. 1628
OFFICE OF POLICY FOR PHARMACEUTICAL QUALITY (OPPQ)
Director Ashley Boam, B.S.E., M.S.B.E. 301-796-6341 WO 51/Rm. 4192
Deputy Director Brian Hasselbalch, B.S. (Acting) 301-796-3279 WO 51/Rm. 4364
Division of Regulations, Guidance and Standards (DRGS) Director Grace McNally 301-796-3286 WO 51/Rm. 4374
Division of Internal Policies and Programs (DIPP) Director Laurie Graham, B.S., M.S. 301-796-5216 WO 51/Rm. 4234
OFFICE OF PROCESS AND FACILITIES (OPF) Director
Lawrence Yu, Ph.D. (Acting) 240-402-3116 WO 51/Rm. 4178
Deputy Director Lynne Ensor (Acting) 240-402-8627 WO 51/Rm. 2272
Division of Process Assessment I (DPAI) Director Rapti Madurawe 301-796-1408 WO 51/Rm. 2278
Division of Process Assessment II (DPAII) Director Sharmista Chatterjee 301-796-2252 WO 51/Rm. 4324
Division of Process Assessment III (DPAIII) Director Naiqi Ya 240-402-9121 WO 51/Rm. 2276
Division of Microbiology Assessment (DMA) Director Vacant
Division of Inspectional Assessment (DIA) Director LCDR Mahesh Ramanadham (Acting) 301-796-3272 WO 51/Rm. 4238
OFFICE OF SURVEILLANCE (OS) Director Lucinda Buhse, Ph.D. 240-402-4595 WO 51/Rm. 4142
Deputy Director
Lyle Canida 301-796-1242 WO 51/Rm. 4134 Division of Quality Intelligence, Risk Analysis and Modeling (DQIRAM) Director Jennifer Maguire 240-402-4817 WO 51/Rm. 2208 Division of Quality Surveillance Assessment (DQSA) Director Teddi Lopez 301-796-3255 WO 51/Rm. 3244
OFFICE OF TESTING AND RESEARCH (OTR) Director David Keire, Ph.D. (Acting) 314-539-3850 St. Louis Mo. Deputy Director Larry (Sau) Lee, Ph.D. 301-796-2905 WO 22/Rm. 2130
Division of Product Quality Research (DPQR) Director
Celia Cruz, Ph.D. 301-796-2143 WO 64/Rm. 1070
Division of Pharmaceutical Analysis (DPA) Director Jason Rodriguez (Acting) 314-539-3855 St. Louis Mo.
OFFICE OF PROGRAM AND REGULATORY OPERATIONS (OPRO) Director Giuseppe Randazzo 301-796-3277 WO 75/Rm. 4514
Deputy Director Vacant
Division of Regulatory and Business Process Management I (DRBPMI) Director Tanya Clayton (Acting) 301-796-0871 WO 75/Rm. 4506
Division of Regulatory and Business Process Management II (DRBPMII) Director Robert Gaines 240-402-4799 WO 75/Rm. 4526
Division of Operational Excellence, Learning and Professional Development (DOELPD) Director Lloyd Ballou, (Acting) 240-402-9016 WO 75/Rm. 3678
OFFICE OF LIFECYCLE DRUG PRODUCTS (OLDP)
Director Susan Rosencrance, Ph.D. 240-402-9068 WO 75/Rm. 5514
Deputy Director Glen Smith, Ph.D. 240-402-9092 WO 75/Rm. 5722
Division of Immediate Release Products I (DIRPI) Director Vilayat Sayeed, Ph.D. 240-402-9077 WO 75/Rm. 5518
Division of Immediate Release Products II (DIRPII) Director Peter Capella, Ph.D. 240-402-8905 WO 75/Rm. 5510
Division of Modified Release Products (DMRP) Director Bhagwant Rege, Ph.D. 240-402-9064 WO 75/Rm. 5724
Division of Liquid-Based Products (DLBP) Director Bing Cai, Ph.D. 240-402-8902 WO 75/Rm. 5716
Director of Post-Marketing Activities I (DPMAI) Director
Hasmukh Patel, Ph.D. 301-796-1432 WO 21/Rm. 2616
Division of Post-Marketing Activities II (DPMAII) Director Paul Schwartz 240-402-8776 WO 75/Rm. 6720